Linagliptin versus sitagliptin in patients with type 2 diabetes mellitus: a network meta-analysis of randomized clinical trials

BACKGROUND: Diabetes is one of the most common chronic and costly diseases worldwide and type 2 diabetes is the most common type which accounts for about 90% of cases with diabetes. New medication-therapy regimens such as those containing linagliptin alone or in combination with other medications (w...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Daru
Main Authors: Keshavarz, Khosro, Lotfi, Farhad, Sanati, Ehsan, Salesi, Mahmood, Hashemi-Meshkini, Amir, Jafari, Mojtaba, Mojahedian, Mohammad M., Najafi, Behzad, Nikfar, Shekoufeh
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Review Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5655990/
https://ncbi.nlm.nih.gov/pubmed/29070077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40199-017-0189-6
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki